NexgenRx and CannTrust Partner to Provide Medical Cannabis Benefit Access and Real Time Adjudication Services to NexgenRx Plan Members

Toronto, Ontario, Canada​​

May​​ 1st,​​ 2018


Toronto, Ontario,​​ May 1, 2018​​ – NEXGENRX INC.​​ (“NexgenRx”​​ or the “Company”, TSX-V: NXG)​​ is pleased to​​ announce that it has signed an​​ exclusive agreement with​​ CannTrust​​ Inc.​​ (“CannTrust®“),​​ one of Canada’s leading licensed producers of​​ medical​​ cannabis​​ and a wholly-owned subsidiary of​​ CannTrust​​ Holdings Inc.​​ (“CannTrust”, TSX: TRST),​​ to create a simple,​​ seamless ordering process for​​ NexgenRx​​ plan members.​​ The agreement is for an initial​​ five (5)​​ year renewable​​ term.​​ 

CannTrust®​​ offers​​ NexgenRx​​ plan sponsors and​​ plan members (i.e.patients)​​ the broadest range of industry leading, high quality, standardized​​ medical​​ cannabis products.​​ CannTrust®®, a​​ pharmacist-led, innovative organization,​​ continues to​​ develop​​ new formats to deliver safe and convenient dosage​​ forms for its patients.​​ With the recent launch of CannTrust®‘s hard shell vegan capsules, patients now have multiple safe​​ and​​ easy-to-administer​​ familiar​​ dosage formats of medical cannabis. ​​ 

NexgenRx will be offering plan sponsors who desire access to these products for their​​ plan​​ members a physician controlled, prescription process.​​ With this agreement,​​ NexgenRx​​ plan​​ members will now be able to order​​ their medical cannabis products from​​ CannTrust®​​ and​​ have​​ a​​ portion of their prescription covered, calculated and applied in real-time​​ by their​​ health care benefits​​ plan.​​ NexgenRx’s compliance tracking and a sophisticated​​ drug​​ utilization​​ review​​ (DUR)​​ process will provide clinical scrutiny as part of the adjudication approval process.​​ At check-out,​​ NexgenRx​​ plan​​ members​​ will only be required to pay the amount not covered by their​​ plan. ​​​​ This​​ real-time adjudication​​ creates​​ a smooth​​ and convenient process for patients,​​ a​​ first of its kind​​ for​​ the​​ medical cannabis market.

“We are delighted to be aligned​​ with CannTrust®,​​ along with​​ their​​ experienced​​ management team made up of pharmacists, physicians,​​ nurses​​ and clinicians.​​ Together we lead the​​ group benefits​​ market in recognizing the changing needs of plan sponsors and​​ their​​ members with regards to​​ medical​​ cannabis​​ and will be​​ offering​​ access to​​ standardized​​ cannabis​​ products​​ to​​ members of​​ plan sponsors​​ who request this coverage.”​​ said​​ Ron Loucks,​​ President &​​ CEO​​ of​​ NexgenRx.

“CannTrust®​​ is focused on providing high quality​​ products and​​ service to our patients.​​ Having a​​ real time​​ adjudication process​​ will​​ make it easier and more convenient for​​ NexgenRx plan members to purchase​​ medical​​ cannabis, while maintaining the integrity of health care plans.​​ We​​ chose​​ to partner with​​ NexgenRx because they are​​ a strong technology​​ solutions provider,​​ representing plan sponsors and​​ hundreds of thousands of their members.​​ We​​ will be​​ offering​​ NexgenRx​​ plan members​​ a seamless​​ experience when purchasing medical cannabis”​​ said​​ Brad Rogers, President of​​ CannTrust®. 

About NexgenRx

NexgenRx is Canada’s only independent full​​ service claims adjudicator with full front end administration capability. These​​ combined​​ capabilities allow NexgenRx to provide complete solutions to plan sponsors that need sophisticated health benefit technology applications in a cost- effective manner. NexgenRx is committed to building partnerships with organizations looking to exceed the expectations of their clients and deliver superior administration and claims processing solutions at a competitive cost. More information on NexgenRx can be found at​​

About CannTrust​​ 

CannTrust®​​ is a federally regulated licensed producer​​ of medical cannabis​​ who brings more than 40 years of pharmacy and healthcare experience to the industry.​​ CannTrust®​​ applies​​ this expertise to produce ​​ standardized​​ medical​​ cannabis​​ at its two state-of-the-art facilities located in Ontario.​​ More information on​​ CannTrust​​ can be found at​​

Caution Regarding Forward-Looking Statements​​ 

Except for statements of historical fact, this news release contains certain​​ “forward-looking information”​​ within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as​​ “plan”,​​ “expect”,​​ “project”,​​ “intend”,​​ “believe”,​​ “anticipate”,​​ “estimate”​​ and other similar words, or statements that certain events or conditions​​ “may”​​ or​​ “will”​​ occur. ​​ Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information.

Forward-looking information is based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. ​​ Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: uncertainty as to whether our strategies and business plans will yield the expected benefits; availability and cost of capital; the ability to identify and develop and achieve commercial success for existing and new products and technologies; the level of expenditures necessary to maintain and improve the quality of products and services; changes in technology and changes in laws and regulations; continued development and enhancement of the Companys proprietary software technology; cyber security risks and the other risks and uncertainties disclosed in our annual Managements Discussion and Analysis, as filed under our profile on SEDAR at​​ ​​ Readers are cautioned that this list of risk factors should not be construed as exhaustive. ​​ 

The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. ​​ Readers are cautioned not to place undue reliance on forward-looking information.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the​​ release.

The TSX does not accept responsibility for the adequacy or accuracy of this release.


Ronald C. Loucks
NexgenRx Inc.
President and CEO
416.695.3393 x801

Kelly Ehler CA​​
NexgenRx Inc.
Chief​​ Financial Officer


Since 2013 CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories.


Subscribe Now


© CannTrust 2019

Terms & Conditions | Accessibility

Pin It on Pinterest